Clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 and 5D: The OCEANOS study in Iran

Nafar, M. and Farokhi, F. R. and Zeraati, A. A. and Ossareh, S. and Atapour, A. and Nemati, E. and Gholi, F. P. R. and Sagheb, M. M. and Hakemi, M. S. and Argani, H. and Tara, S. A. and Afshar, R. and Ahmadi, J. M. R. and Karimi, N. and Mamdouhi, F. and Mahdavi-Mazdeh, M. and Sabaghian, T. (2018) Clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 and 5D: The OCEANOS study in Iran. Nephro-Urology Monthly, 10 (1).

[img] Text
Clinical practices and therapeutic management of mineral and bone disorders in chronic kidney disease 4, 5 and 5D The OCEANOS study in Iran.pdf

Download (185kB)

Abstract

Background: The aim of this study was to evaluate the management of mineral and bone disorders (MBD) in patients with chronic kidney disease (CKD) in Iran and the extent to which KDIGO goals were met. Methods: This multi-centre observational studywasconductedonpatients withCKDstages 4, 5, and5D. Data were collectedfroma total of 209patients withnosurgical or medical conditions that precluded their participation. This study assessed the frequency of measurements, serum levels of phosphorus (P), calcium (Ca), and parathyroid hormone (PTH), the achievement of the targets recommended by the 2009 KDIGO guidelines, and the presence of vascular/valvular calcification. Results: The KDIGO targets for P, Ca, and iPTH, were achieved in 47, 51, and 18 of the patients with stage 4 + 5 and in 63, 50, and 44 of the patients with stage 5D, respectively. The serum PTH level of 18 of the patients with CKD stage 4 + 5 was within the recommended range, while it was higher than the recommended level in other patients. Among patients with CKD stage 5D, the serum PTH level was within, below, and above the recommended range in 44, 39, and 17 of the patients, respectively. The frequency of the measurement of the blood levels of Ca, P, and PTH were based on the 2009 KDIGO guidelines in 88 of patients. Forty-six percent of cases were screened for vascular/valvular calcification, 30 of whom had calcification at least in one site. Conclusions: The current status is far from the targets recommended by the current guidelines in the management of CKD-MBD. © 2017, Nephro-Urology Monthly.

Item Type: Article
Additional Information: Export Date: 16 February 2020 Correspondence Address: Sabaghian, T.; Department of Nephrology, Taleghani Hospital, Floor 1, Arabi Alley, Velenjak St, Iran; email: ph.sabaghian@gmail.com
Uncontrolled Keywords: Calcium Chronic kidney disease Mineral and bone disorders Parathyroid hormone (PTH) Phosphorus parathyroid hormone adult aged Article blood vessel calcification calcium blood level chronic kidney disease-mineral and bone disorder chronic kidney failure clinical practice diabetes mellitus disease management disease severity female human Iran major clinical study male observational study parathyroid hormone blood level phosphate blood level practice guideline
Subjects: WE Musculoskeletal system
WJ Urogenital System
Divisions: Mashhad University of Medical Sciences
Depositing User: lib2 lib2 lib2
Date Deposited: 08 May 2020 15:14
Last Modified: 08 May 2020 15:14
URI: http://eprints.mums.ac.ir/id/eprint/17438

Actions (login required)

View Item View Item